Gainers & Losers
Fri Nov 14 2025 09:58:56- Eternal share price
- ₹304.452.27%
- Trent share price
- ₹4,390.001.57%
- Axis Bank share price
- ₹1,243.801.54%
- Bharat Electronics share price
- ₹426.051.49%
- Bajaj Finance share price
- ₹1,018.951.37%
Active Stocks
Fri Nov 14 2025 10:24:22- Samvardhana Motherson Inte...
- ₹109.800.60%
- Yes Bank share price
- ₹22.490.04%
- Suzlon Energy share price
- ₹57.580.03%
- Adani Power share price
- ₹153.901.32%
- Canara Bank share price
- ₹146.051.81%
Piramal Pharma Profit & Loss Annual
194.10 +0.25 (0.13%)Updated : 14 Nov 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 8,442.52 | 6,683.37 | 5,937.62 | 5,264.90 |
| Other Net | -425.91 | -1,413.38 | -1,322.13 | -891.52 |
| Diluted Weighted Average Shares | 133.07 | 128.11 | 121.87 | 120.72 |
| Gain( Loss)on Saleof Assets | 1.44 | -0.46 | -0.48 | -0.54 |
| Depreciation/ Amortization | 771.59 | 740.57 | 676.69 | 586.18 |
| Operating Income | 708.66 | 1,487.79 | 1,143.93 | 1,294.20 |
| Net Income | 91.13 | 17.82 | -186.46 | 375.96 |
| Income Availableto Com Excl Extra Ord | 91.13 | 17.82 | -186.46 | 375.96 |
| Other Operating Expenses Total | 1,015.25 | -50.92 | -159.77 | -77.00 |
| Net Income Before Taxes | 414.64 | 179.29 | -120.15 | 484.98 |
| Net Income After Taxes | 91.13 | 17.82 | -186.46 | 375.96 |
| Income Availableto Com Incl Extra Ord | 91.13 | 17.82 | -186.46 | 375.96 |
| Costof Revenue Total | 3,498.81 | 3,195.59 | 2,911.11 | 2,614.80 |
| Gross Profit | 5,652.37 | 4,975.57 | 4,170.44 | 3,944.30 |
| Interest Inc( Exp) Net- Non- Op Total | 130.45 | 105.34 | 58.53 | 82.84 |
| Unusual Expense( Income) | 94.90 | 62.79 | 6.96 | 15.08 |
| Diluted Net Income | 91.13 | 17.82 | -186.46 | 375.96 |
| DPS- Common Stock Primary Issue | 0.14 | 0.11 | - | 0.00 |
| Provisionfor Income Taxes | 323.51 | 161.47 | 66.31 | 109.02 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 91.13 | 17.82 | -186.46 | 375.96 |
| Total Revenue | 9,151.18 | 8,171.16 | 7,081.55 | 6,559.10 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 9,151.18 | 8,171.16 | 7,081.55 | 6,559.10 |
| Selling/ General/ Admin Expenses Total | 2,964.84 | 2,634.67 | 2,416.27 | 1,997.50 |
| Diluted Normalized EPS | 1.14 | 0.46 | -1.49 | 3.21 |
| Research Development | 97.13 | 100.67 | 86.36 | 128.34 |
| Diluted EPS Excluding Extra Ord Items | 0.68 | 0.14 | -1.53 | 3.11 |
*All figures in crores except per share values
Piramal Pharma Quick Links
Piramal Pharma Dividend Piramal Pharma Bonus Piramal Pharma News Piramal Pharma AGM Piramal Pharma Rights Piramal Pharma Splits Piramal Pharma Board Meetings Piramal Pharma Key Metrics Piramal Pharma Shareholdings Piramal Pharma Balance Sheet Piramal Pharma Cashflow Piramal Pharma Q1 Results Piramal Pharma Q2 Results Piramal Pharma Q3 Results Piramal Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
304.45+6.75(2.27%)
1,245.75+20.85(1.70%)
426.90+7.10(1.69%)
1,506.15-36.20 (-2.35%)
174.10-2.50 (-1.42%)